Mild Cognitive Impairment in Parkinson's Disease-What Is It?

被引:66
|
作者
Weil, Rimona S. [1 ,2 ]
Costantini, Alyssa A. [2 ]
Schrag, Anette E. [3 ,4 ]
机构
[1] UCL, Dementia Res Ctr, London, England
[2] UCL, Dept Neurodegenerat, London, England
[3] UCL, Dept Clin Neurosci, London, England
[4] UCL, Inst Neurol, Rowland Hill St, London NW3 2PF, England
基金
英国经济与社会研究理事会;
关键词
Parkinson's disease; Mild cognitive impairment; Dementia; ALZHEIMERS-DISEASE; ALPHA-SYNUCLEIN; LEWY BODIES; DIAGNOSTIC-CRITERIA; SENILE-DEMENTIA; CSF A-BETA(42); FOLLOW-UP; BRAIN; DECLINE; PREDICTION;
D O I
10.1007/s11910-018-0823-9
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Purpose of Review Mild cognitive impairment is a common feature of Parkinson's disease, even at the earliest disease stages, but there is variation in the nature and severity of cognitive involvement and in the risk of conversion to Parkinson's disease dementia. This review aims to summarise current understanding of mild cognitive impairment in Parkinson's disease. We consider the presentation, rate of conversion to dementia, underlying pathophysiology and potential biomarkers of mild cognitive impairment in Parkinson's disease. Finally, we discuss challenges and controversies of mild cognitive impairment in Parkinson's disease. Recent Findings Large-scale longitudinal studies have shown that cognitive involvement is important and common in Parkinson's disease and can present early in the disease course. Recent criteria for mild cognitive impairment in Parkinson's provide the basis for further study of cognitive decline and for the progression of different cognitive phenotypes and risk of conversion to dementia. Summary Improved understanding of the underlying pathology and progression of cognitive change are likely to lead to opportunities for early intervention for this important aspect of Parkinson's disease.
引用
收藏
页数:11
相关论文
共 50 条
  • [21] Evaluation of Mild Cognitive Impairment Subtypes in Parkinson's Disease
    Cholerton, Brenna A.
    Zabetian, Cyrus P.
    Wan, Jia Y.
    Montine, Thomas J.
    Quinn, Joseph F.
    Mata, Ignacio F.
    Chung, Kathryn A.
    Peterson, Amie
    Espay, Alberto J.
    Revilla, Fredy J.
    Devoto, Johnna
    Watson, G. Stennis
    Hu, Shu-Ching
    Leverenz, James B.
    Edwards, Karen L.
    MOVEMENT DISORDERS, 2014, 29 (06) : 756 - 764
  • [22] Mild Cognitive Impairment and Parkinson's Disease - Something to Remember
    Barker, Roger A.
    Williams-Gray, Caroline H.
    JOURNAL OF PARKINSONS DISEASE, 2014, 4 (04) : 651 - 656
  • [23] Exploratory analysis of neuropsychological and neuroanatomical correlates of progressive mild cognitive impairment in Parkinson's disease
    Lee, Ji E.
    Cho, Kyoo H.
    Song, Sook K.
    Kim, Hee Jin
    Lee, Hye Sun
    Sohn, Young H.
    Lee, Phil Hyu
    JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2014, 85 (01): : 7 - 16
  • [24] Subtypes of mild cognitive impairment in Parkinson's disease and factors predicting its becoming dementia
    Elena Toribio-Diaz, M.
    Carod-Artal, Francisco J.
    REVISTA DE NEUROLOGIA, 2015, 61 (01) : 14 - 24
  • [25] Clinical differences among mild cognitive impairment subtypes in Parkinson's disease
    Goldman, Jennifer G.
    Weis, Holly
    Stebbins, Glenn
    Bernard, Bryan
    Goetz, Christopher G.
    MOVEMENT DISORDERS, 2012, 27 (09) : 1129 - 1136
  • [26] Evolution of diagnostic criteria and assessments for Parkinson's disease mild cognitive impairment
    Goldman, Jennifer G.
    Holden, Samantha K.
    Litvan, Irene
    McKeith, Ian
    Stebbins, Glenn T.
    Taylor, John-Paul
    MOVEMENT DISORDERS, 2018, 33 (04) : 503 - 510
  • [27] Mild cognitive impairment in Parkinson's disease: the Parkinson's disease cognitive study (PACOS)
    Monastero, Roberto
    Cicero, Calogero Edoardo
    Baschi, Roberta
    Davi, Marco
    Luca, Antonina
    Restivo, Vincenzo
    Zangara, Chiara
    Fierro, Brigida
    Zappia, Mario
    Nicoletti, Alessandra
    JOURNAL OF NEUROLOGY, 2018, 265 (05) : 1050 - 1058
  • [28] Beta Amyloid Deposition Is Not Associated With Cognitive Impairment in Parkinson's Disease
    Melzer, Tracy R.
    Stark, Megan R.
    Keenan, Ross J.
    Myall, Daniel J.
    MacAskill, Michael R.
    Pitcher, Toni L.
    Livingston, Leslie
    Grenfell, Sophie
    Horne, Kyla-Louise
    Young, Bob N.
    Pascoe, Maddie J.
    Almuqbel, Mustafa M.
    Wang, Jian
    Marsh, Steven H.
    Miller, David H.
    Dalrymple-Alford, John C.
    Anderson, Tim J.
    FRONTIERS IN NEUROLOGY, 2019, 10
  • [29] Mild cognitive impairment: an update in Parkinson's disease and lessons learned from Alzheimer's disease
    Goldman, Jennifer G.
    Aggarwal, Neelum T.
    Schroeder, Cynthia D.
    NEURODEGENERATIVE DISEASE MANAGEMENT, 2015, 5 (05) : 425 - 443
  • [30] Donepezil for mild cognitive impairment in Parkinson's disease
    Baik, Kyoungwon
    Kim, Seon Myeong
    Jung, Jin Ho
    Lee, Yang Hyun
    Chung, Seok Jong
    Yoo, Han Soo
    Ye, Byoung Seok
    Lee, Phil Hyu
    Sohn, Young H.
    Kang, Seung Wan
    Kang, Suk Yun
    SCIENTIFIC REPORTS, 2021, 11 (01)